These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 22950447)

  • 41. Pharmacologic management of anorexia/cachexia.
    Ottery FD; Walsh D; Strawford A
    Semin Oncol; 1998 Apr; 25(2 Suppl 6):35-44. PubMed ID: 9625382
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Ghrelin and its analogues as therapeutic agents for anorexia and cachexia in end-stage renal disease.
    Cheung WW; Mak RH
    Kidney Int; 2009 Jul; 76(2):135-7. PubMed ID: 19564855
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Megestrol acetate for the treatment of anorexia-cachexia syndrome.
    Berenstein EG; Ortiz Z
    Cochrane Database Syst Rev; 2005 Apr; (2):CD004310. PubMed ID: 15846706
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Treatment of anorexia with megestrol acetate.
    Tchekmedyian NS
    Nutr Clin Pract; 1993 Jun; 8(3):115-8. PubMed ID: 8289758
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Novel treatments for cancer cachexia.
    Bossola M; Pacelli F; Doglietto GB
    Expert Opin Investig Drugs; 2007 Aug; 16(8):1241-53. PubMed ID: 17685872
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Low-dose megestrol acetate for appetite stimulation in advanced cancer.
    Donnelly S; Walsh TD
    J Pain Symptom Manage; 1995 Apr; 10(3):182-3. PubMed ID: 7629410
    [No Abstract]   [Full Text] [Related]  

  • 47. [The tumor-cahexy syndrome. Poor general health--a complex problem].
    Radiologe; 1998 Oct; 38(10 Suppl):1-4. PubMed ID: 9834973
    [No Abstract]   [Full Text] [Related]  

  • 48. Megestrol acetate for cachexia-anorexia syndrome. A systematic review.
    Ruiz-García V; López-Briz E; Carbonell-Sanchis R; Bort-Martí S; Gonzálvez-Perales JL
    J Cachexia Sarcopenia Muscle; 2018 Jun; 9(3):444-452. PubMed ID: 29542279
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Comparison of orally administered cannabis extract and delta-9-tetrahydrocannabinol in treating patients with cancer-related anorexia-cachexia syndrome: a multicenter, phase III, randomized, double-blind, placebo-controlled clinical trial from the Cannabis-In-Cachexia-Study-Group.
    ; Strasser F; Luftner D; Possinger K; Ernst G; Ruhstaller T; Meissner W; Ko YD; Schnelle M; Reif M; Cerny T
    J Clin Oncol; 2006 Jul; 24(21):3394-400. PubMed ID: 16849753
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Pentoxifylline for treatment of cancer anorexia and cachexia? A randomized, double-blind, placebo-controlled trial.
    Goldberg RM; Loprinzi CL; Mailliard JA; O'Fallon JR; Krook JE; Ghosh C; Hestorff RD; Chong SF; Reuter NF; Shanahan TG
    J Clin Oncol; 1995 Nov; 13(11):2856-9. PubMed ID: 7595749
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Alleviation of cancer anorexia and cachexia: studies of the Mayo Clinic and the North Central Cancer Treatment Group.
    Loprinzi CL; Ellison NM; Goldberg RM; Michalak JC; Burch PA
    Semin Oncol; 1990 Dec; 17(6 Suppl 9):8-12. PubMed ID: 2259930
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Oxidative stress and wasting in cancer.
    Laviano A; Meguid MM; Preziosa I; Rossi Fanelli F
    Curr Opin Clin Nutr Metab Care; 2007 Jul; 10(4):449-56. PubMed ID: 17563463
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Cytokines and cancer anorexia cachexia syndrome.
    Bennani-Baiti N; Davis MP
    Am J Hosp Palliat Care; 2008; 25(5):407-11. PubMed ID: 18403577
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Is ATP (adenosine 5'-triphosphate), like STP, a performance-enhancing additive for the tanks of cancer patients?
    Jatoi A; Loprinzi CL; Sloan J; Goldberg RM
    J Natl Cancer Inst; 2000 Feb; 92(4):290-1. PubMed ID: 10675368
    [No Abstract]   [Full Text] [Related]  

  • 55. Phase II trial of mirtazapine for cancer-related cachexia and anorexia.
    Riechelmann RP; Burman D; Tannock IF; Rodin G; Zimmermann C
    Am J Hosp Palliat Care; 2010 Mar; 27(2):106-10. PubMed ID: 19776373
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Prospective randomised trial of two dose levels of megestrol acetate in the management of anorexia-cachexia syndrome in patients with metastatic cancer.
    Gebbia V; Testa A; Gebbia N
    Br J Cancer; 1996 Jun; 73(12):1576-80. PubMed ID: 8664133
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effects of megestrol acetate in patients with cancer anorexia-cachexia syndrome--a systematic review and meta-analysis.
    Leśniak W; Bała M; Jaeschke R; Krzakowski M
    Pol Arch Med Wewn; 2008 Nov; 118(11):636-44. PubMed ID: 19140567
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Diagnostic criteria for cancer cachexia: data versus dogma.
    Martin L
    Curr Opin Clin Nutr Metab Care; 2016 May; 19(3):188-98. PubMed ID: 26945342
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Novel herbal medicine LA16001 ameliorates cisplatin-induced anorexia.
    Woo SM; Lee KM; Lee GR; Park JY; Lee HJ; Bahn HJ; Yoon HS; Kim JY; Shin YC; Cho SG; Ko SG
    Mol Med Rep; 2018 Feb; 17(2):2665-2672. PubMed ID: 29207134
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Molecular Pathways: Cachexia Signaling-A Targeted Approach to Cancer Treatment.
    Miyamoto Y; Hanna DL; Zhang W; Baba H; Lenz HJ
    Clin Cancer Res; 2016 Aug; 22(16):3999-4004. PubMed ID: 27340276
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.